Beijing, China

Haitang Li

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 10.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Haitang Li in Central Nervous System Research

Introduction

Haitang Li, an esteemed inventor located in Beijing, China, has made significant strides in the field of pharmacological research, focusing on compounds that exhibit potential therapeutic effects for various central nervous system disorders. With two patents to his name, his work represents a fusion of scientific inquiry and innovation, aimed at addressing complex neurological and psychiatric conditions.

Latest Patents

Haitang Li's latest patents include two notable inventions:

1. **Triazolyl Pyrimidinone Compounds as PDE2 Inhibitors**: This invention is directed towards pyrimidine carboxamide compounds, which are identified as useful therapeutic agents for treating central nervous system disorders related to phosphodiesterase 2 (PDE2). The compounds hold promise for alleviating symptoms associated with conditions such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), and Huntington's disease. They specifically target disorders linked to striatal hypofunction or basal ganglia dysfunction.

2. **6-Alkyl Dihydropyrazolopyrimidinone Compounds as PDE2 Inhibitors**: Similar to his first patent, this invention centers on 6-alkyl dihydropyrazolopyrimidinone compounds, characterized as valuable therapeutic agents for central nervous system disorders associated with PDE2. These compounds are also being explored for their potential to treat neurological and psychiatric disorders, including schizophrenia, psychosis, Parkinson's disease, PDD, and Huntington's disease, focusing on dysfunctions affecting the striatum or basal ganglia.

Career Highlights

Currently, Haitang Li is associated with Merck Sharp & Dohme Corporation, a leader in the pharmaceutical industry. His work contributes to a legacy of medical advancements, showcasing a commitment to research and development geared towards improving patient outcomes in the realm of mental health and neurological disorders.

Collaborations

During his career, Haitang Li has collaborated with esteemed colleagues, including Dong-Ming Shen and Christopher Joseph Sinz. These partnerships enhance the research landscape and promote interdisciplinary approaches to tackling complex medical challenges.

Conclusion

Haitang Li's innovative contributions to the field of central nervous system research underscore the importance of continued exploration in pharmacology. Through his patents, he is paving the way for new treatments that could significantly improve the quality of life for individuals affected by serious neurological and psychiatric disorders. His dedication to scientific excellence at Merck Sharp & Dohme Corporation illustrates the vital role of inventors in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…